Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.1800
0.00040.22%
Last update: Oct 9, 7:44 PM
$0.1800
0.00040.22%
AIM ImmunoTech Inc (AIM) Stock Price, Quote, News & History
AIMAMEX
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of AIM ImmunoTech (AMEX:AIM) through any online brokerage.
Other companies in AIM ImmunoTech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
AIM ImmunoTech has a consensus price target of $4.00.
The stock price for AIM ImmunoTech (AMEX: AIM) is $0.18 last updated October 9, 2026 at 7:44 PM EDT.
There are no upcoming dividends for AIM ImmunoTech.
AIM ImmunoTech does not have any upcoming earnings scheduled.
There is no upcoming split for AIM ImmunoTech.
AIM ImmunoTech is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
